Máfia/WS: 86 15132971817

      E-mail: admin@mokemei.com

PNC-27

PNC-27

01.Sommarlutide is a long-acting formulation based on the basic structure of Liraglutide, which is more effective in the treatment of type 2 diabetes..

02.Semeglutide is a GLP-1(7-37) chain with 8-position Aib replacing Ala, 34-position Arg replacing Lys, and 26-position Lys attached to the stearic acid fatty chain.

03.Compared with Liraglutide, Semeglutide's fat Chemicalbook chain is longer and its hydrophobicity is increased, but Semeglutide is modified with short chain PEG and its hydrophilicity is greatly enhanced.

04.After PEG modification, it can not only bind to albumin closely, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong biological half-life, and achieve a long cycle effect.
Preço: $0.00

Padrão de nota

Grau de Medicina

Tipo

Reagente Químico

Estado

Sólido

Volátil

Não volátil

Nome dos produtos

PNC-27

Prazo de validade

1 ano

Condição de armazenamento

Normal

Cor

Amostra

Disponível

Standaed

BPF

Ensaio

>99%

CAS

9104 63-68-2

Ponto de fusão

89ºC

Rotação Específica

25D -256°

Entrega

5-8 dias

Ponto de ebulição

574,5±50,0 °c (Previsto)

Mf

C187h291n45o59

Merck

14, 8090

KPa

13.63±0.46

Pacote de Transporte

Caixa

Especificação

10g/GARRAFA

Marca registrada

Jinan Andechem

Origem

mulheres

Código HS

29309090

Capacidade de produção

5000kg/mês
















Descrição:

01.Sommarlutide is a long-acting formulation based on the basic structure of Liraglutide, which is more effective in the treatment of type 2 diabetes..

02.Semeglutide is a GLP-1(7-37) chain with 8-position Aib replacing Ala, 34-position Arg replacing Lys, and 26-position Lys attached to the stearic acid fatty chain.

03.Compared with Liraglutide, Semeglutide's fat Chemicalbook chain is longer and its hydrophobicity is increased, but Semeglutide is modified with short chain PEG and its hydrophilicity is greatly enhanced.

04.After PEG modification, it can not only bind to albumin closely, cover the hydrolysis site of DPP-4 enzyme, but also reduce renal excretion, prolong biological half-life, and achieve a long cycle effect.

USD:

Se maglutida (Rybelsus, O zempic, NN9535, OG217SC, NNC 0113-0217) é um análogo do peptídeo 1 semelhante ao glucagon (GLP-1) de ação prolongada e agonista do receptor GLP-1. Tem potencial eficácia terapêutica para diabetes mellitus tipo 2 (DM2).

Nome
Telefone
E-mail
Razão social
Endereço
Deixando mensagem*
 
Código de verificação
Enviar
Anterior: PT-141
Próximo: Pinealon